SAFETY, TOLERABILITY, PHARMACOKINETIC AND PHARMACODYNAMIC EFFECT OF BIIB059, A MONOCLONAL ANTIBODY TARGETING BDCA2 FOLLOWING ADMINISTRATION OF SUBCUTANEOUS SINGLE DOSES IN JAPANESE HEALTHY VOLUNTEERS-MedSci.cn

SAFETY, TOLERABILITY, PHARMACOKINETIC AND PHARMACODYNAMIC EFFECT OF BIIB059, A MONOCLONAL ANTIBODY TARGETING BDCA2 FOLLOWING ADMINISTRATION OF SUBCUTANEOUS SINGLE DOSES IN JAPANESE HEALTHY VOLUNTEERS

Musselli, C; Gaudreault, F; Naik, H; Carroll, H; Sharma, A; Huang, XB; Franchimont, N